MANAGEMENT TEAM The MMI Management team is enthusiastic about advancing the future of microsurgery by launching a unique surgical robot in the market. This group of seasoned professionals is leading the company by bringing decades of experience from diverse backgrounds together. They’re on a mission to improve patient care and reduce overall healthcare costs by expanding the accessibility and applications of microsurgery. MARK TOLAND CEO Mark Toland is the CEO of MMI SpA. Before joining MMI, Mark served as the President and CEO of Corindus where he transformed the company into the industry leader in vascular robotics with the only approved system for coronary, peripheral and neurovascular indications. The Siemens Healthineers acquisition of Corindus for $1.1 billion was the fifth largest medical technology acquisition of 2019. Prior to Corindus, Mark served as Senior Vice President of Boston Scientific, where he built the company’s global solutions business and led all aspects of the U.S. commercial team’s cardiovascular businesses, which represented approximately $4 billion in revenue. Mark brings over 25 years of medical device experience to MMI. In addition, he serves on the Board of Directors for Cardiologs, a cardiovascular AI company, and Amplitude Vascular Systems, an Intravascular Lithotripsy company. He also serves as a partner and EIR at Biostar Capital, a healthcare focused Venture Capital firm. Mr. Toland holds a Bachelor of Science in Business Administration from the University of Louisville. GIANLUCA LANDI CFO Mr. Landi has expertise in accounting and implementing reporting activities for obtaining reliable and timely data. Throughout his career he has developed a strong focus on product cost rationalization. In addition, he held leading roles related to production control systems, mergers and acquisitions, crisis management, corporate reorganizations (including union relations), and corporate culture change. His knowledge of Lean Production has been vital for establishing more efficient and cost-effective production flows in the organizations where he has worked. Gianluca holds a Master’s Degree in Audit & Management Control from Pisa University. MAURO ERCOLANI VP QUALITY & REGULATORY AFFAIRS Mr. Ercolani has a multidisciplinary technical background and vast experience in Regulatory Affairs. Early in his career, he worked as a Project Manager and Chief Technical Officer for innovation related projects in the biomedical field. Prior to joining MMI, Mauro served as Director of Regulatory Affairs at LivaNova where he was responsible for the global regulatory activities for the Cardiac Surgery Business Unit. In addition, he is a co-inventor on several international patents. At MMI, Mauro is responsible for shaping the quality system and designing a global regulatory strategy that leverages the clinical value of the robotic platform. Mauro holds a Master’s Degree in Nuclear Engineering from La Sapienza University in Rome. JAMIE MILAS VICE PRESIDENT OF MARKETING Ms. Milas is a marketing professional who has lived and worked in the United States, Belgium, France and Italy. Her career has evolved around several strategic marketing roles, primarily in diagnostic imaging, 3D surgical planning software, and patient-specific implants/instruments. She served as the Global Marketing Manager at Materialise for 8 years before becoming Vice President of Global Marketing at EOS imaging where she continued to lead a team of marketing professionals and product managers. Jamie holds a Bachelor of Science and an MBA in International Business and Marketing from the University of Dayton. MASSIMILIANO SIMI, PH.D. VICE PRESIDENT OF R&D Dr. Simi is one of the founders of MMI SpA. He has more than 10 years of experience in the robotic surgery sector. Massimiliano invented the NanoWrist articulated microinstruments and is listed as an inventor on all MMI patents to date. As the Vice President of R&D, he recruits, develops and manages a growing team of highly skilled engineers involved in New Products Introduction. Before starting the company, Massimiliano was a Senior Mechanical Engineer at MEDRA where he provided technical solutions in the field of robotics and mechatronics to medical device companies based in the Bay Area. Dr. Simi has a Ph.D in Innovative Technologies and Medical Robotics from the prestigious University Scuola Superiore Sant’Anna in Pisa, Italy. His specialization was focused on microfabrication processes applied to endoscopic robotic capsules and magnetic driven laparoscopic cameras which he designed and tested at the STORM Lab of Vanderbilt University. In addition, Dr. Simi has a Bachelor’s and Master’s Degree in Biomedical Engineering from University of Pisa and completed an Executive MBA in 2016. ALAN SIMONIAN DIRECTOR OF GLOBAL COMMERCIAL OPERATIONS Mr. Simonian is the Director of Global Commercial Operations at MMI. Before joining the team, Alan spent 4 years as the Director of Strategic Planning and Global Commercial Operations at Corindus, Inc. prior to the company’s acquisition by Siemens Healthineers. In addition, he has served as the Director of Commercial Operations at XACT Robotics, Manager of Strategy, Contracting and Sales Analytics at Boston Scientific, and an Associate Consultant at Grant Thornton. Alan holds a Bachelor of Science in Corporate Finance and Accounting from Bentley University, and an MBA from Babson College. GIANCARLO TESTAVERDE VICE PRESIDENT OF OPERATIONS Mr. Testaverde is the Vice President of Operations at MMI. Before joining the team, he spent 4 years as the Manufacturing Director at Medtronic for the entire respiratory product range (over 1,500 sku’s) where he was responsible for nearly 600 employees. Simultaneously, he served as the CEO of Mallinckrodt DAR srl. In addition, Giancarlo was the Director of Operations at Titan Italia S.P.A. for 4 years, Director of Quality and Plant Manager at Federal-Mogul for 5 years and the Logistics Manager at Valeo for over 8 years. Mr. Testaverde has a Bachelor of Engineering from Politecnico di Torino, a CPIM - CSC in Supply Chain Management from APICS Northern Colorado and an Executive MBA in Economics and Finance from SDA Bocconi. JOHN VAN VLEET VICE PRESIDENT OF CLINICAL AFFAIRS Mr. Van Vleet (JVV) is a regulatory and clinical affairs leader in the medical device field with a career spanning over three decades. John’s career began in orthopedics at Zimmer, DePuy, Smith&Nephew and then migrated towards vascular medicine where he led the clinical and regulatory teams at Bard's Peripheral Vascular division, completed several PMA clinical trials and approvals and oversaw the Lutonix acquisition/integration. Most recently, he served as the Vice President of Clinical and Regulatory Affairs at Corindus Vascular Robotics, Inc., where he oversaw the first in human remote coronary study and launched the first global robotics neurovascular study. JVV has delivered clinical trial results and regulatory approvals in US, Japan, Korea, and other geographies. Mr. VanVleet graduated from Purdue University with a Bachelor of Science in Biology and Chemistry. He thereafter completed a clinical internship and was Board Certified by the American Society of Clinical Pathology with a license in Medical Technology and holds a Master of Science degree in Management and Marketing from Marion College. From Left to Right: Massimiliano Simi, PhD, Giuseppe Prisco, PhD, and Hannah Teichmann, PhD. PRIVACY POLICY MMI SPA, VIA DEL PADULETTO 10A, CALCI - PISA-, ITALIA +39 0506394MARKETING@MMIMICRO.COM Copyright 2005-2021 MMI S.p.A., all rights reserved.